WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Join the Society for Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, July 12, 2006, ():

This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Submit an eLetter
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions

Pancreatitis-Associated Protein-III Is a Novel Macrophage Chemoattractant Implicated in Nerve Regeneration
J. Neurosci. Namikawa et al. 26: 7460

Supplemental data

Files in this Data Supplement:

  • supplemental material - Supplemental methods
  • supplemental material - Supplemental Figure 1. (A) RT-PCR demonstrating remarkable expression of PAP-III mRNA in the distal parts of injured sciatic nerves at 1 day after axotomy. MCP-1 mRNA expression is also rapidly induced in the injured nerves. The expression of GAPDH mRNA was used as an internal control. (B) SDS-PAGE analysis and subsequent silver staining showing that the purified recombinant PAP-III is exactly the same size as the secreted PAP III protein (arrow) in the supernatant (sup.) of 293T cells transfected with a PAP-III-expressing plasmid. These bands are also recognized by western blotting analysis using an anti-PAP-III antibody (lower).
  • supplemental material - Supplemental Figure 2. Effect of a siRNA expression vector against PAP-III. Different amounts of plasmids expressing PAP-I or PAP-III were co-transfected into COS7 cells together with 300 ng of a siPAP-III-expressing plasmid. Subsequently, western blotting analyses were performed on the cell lysates. Although siPAP-III expression has no effect on the expression of PAP-I (A), it effectively reduces PAP-III expression in a dose-dependent manner (B). The same membrane was reprobed with an anti-GAPDH antibody to confirm that equal amounts of protein were loaded.
  • supplemental material - Supplemental Figure 3. PAP-III has no activity as a Schwann cell mitogen in vitro. (A) A Schwann cell marker, S100 (green) and an indicator of DNA synthesis BrdU (red) double staining of Schwann cells in the absence (left) or presence of PAP-III (middle) or ß-Heregulin (right), one of well-known Schwann mitogens, at the concentration of 50ng/m, respectively. Forskolin (10 µM) was added to the cultures together with these factors. (B) The mean percentage of Schwann cells (S100 positive cells) double-labelled for BrdU incorporation in the 24 h following each treatment. Note that PAP-III failed to stimulate Schwann cell growth even in the presence of Forskolin, whereas the growth of the cells stimulated by ß-Heregulin (Her) was significantly enhanced especially in the presence of Forskolin. Error bars indicate SEM. Scale bar represents 50 µm (A).
  • supplemental material - Supplemental Figure 4. PAP-III has no effect on neurite outgrowth in DRG organ cultures. (A) DRGs were embedded in the collagen gels and cultured for 4 days in the absence (upper; cont) or presence of PAP-III (middle) or NGF (lower) at the concentration of 50ng/ml, respectively. Their neurites were visualized with anti-neurofilament antibody. (B) Neurite length was measured from the surface of DRG. Application of PAP-III at various concentrations has no impact on enhancment of the neurite outgrowth of DRG cells, compared to NGF. Error bars represent SEM. Scale bar represents 500 μm (A)




This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Submit an eLetter
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions

-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-